Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Stress-related hair loss was reversed with a special medication.

An 11-year-old boy in Saudi Arabia has a rare case of hypoparathyroidism with severe brain calcifications but normal development and no known cause.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Vitamin D might help treat some types of hair loss, but more research is needed.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Sertraline, an antidepressant, may rarely cause hair loss.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Sertraline, an antidepressant, may cause hair loss in rare cases.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

A nutrition program improved a young woman's concussion symptoms.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Vitamin B12 deficiency can cause skin darkening and increased blood vessels, but treatment can improve symptoms.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.